Related Experiment Videos
Ciprofloxacin: a study of usage in pedal infections with case reports
Abstract:
Ciprofloxacin, an antibiotic of the quinolone class, has exhibited properties that may lead to frequent use in the febrile patient. Particularly important to the podiatrist is the bactericidal action of the drug on penicillinase producing Staphylococcus aureus and Pseudomonas species. Ciprofloxacin also kills many Gram-negative bacteria, and some anaerobic bacteria. Infections of this nature have been classically treated with parenteral antibiotics in a hospital setting. Ciprofloxacin has demonstrated, in clinical studies, the ability to kill these organisms in skin, soft tissues, and bone while using an oral route of administration. When considering cost-containment strategies in the patient with osteomyelitis, ciprofloxacin can cost between 50% to 80% less than parenteral therapy.
Insights
Ciprofloxacin offers effective oral treatment for bacterial infections, including those affecting bone. This quinolone antibiotic provides a cost-effective alternative to intravenous therapies for conditions like osteomyelitis.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Ciprofloxacin is a quinolone antibiotic with broad-spectrum activity.
- Febrile infections often require potent antimicrobial agents.
- Penicillinase-producing Staphylococcus aureus and Pseudomonas species are common pathogens.
Observation:
- Ciprofloxacin exhibits bactericidal activity against key pathogens.
- The drug demonstrates efficacy in treating skin, soft tissue, and bone infections.
- Oral administration of ciprofloxacin is effective for these infections.
Findings:
- Ciprofloxacin effectively eradicates Staphylococcus aureus and Pseudomonas species.
- The antibiotic is effective against Gram-negative and some anaerobic bacteria.
- Oral ciprofloxacin provides a viable treatment option for osteomyelitis.
Implications:
- Oral ciprofloxacin can replace parenteral antibiotics for certain infections.
- This offers significant cost savings compared to traditional intravenous treatments.
- Podiatrists can utilize ciprofloxacin for bone infections, improving patient management.